INCISIVE Implementation Guide
0.1.1 - draft

INCISIVE Implementation Guide - Local Development build (v0.1.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 General Guidance
... 3 Breast Cancer HL7 FHIR Implementation Guide
... 4 Breast Cancer Logical Model
... 5 Breast Cancer Message Support Guidance
... 6 Colorectal Cancer HL7 FHIR Implementation Guide
... 7 Colorectal Cancer Logical Model
... 8 Colorectal Cancer Message Support Guidance
... 9 Lung Cancer HL7 FHIR Implementation Guide
... 10 Lung Cancer Logical Model
... 11 Lung Cancer Message Support Guidance
... 12 Prostate Cancer HL7 FHIR Implementation Guide
... 13 Prostate Cancer Logical Model
... 14 Prostate Cancer Message Support Guidance
... 15 Downloads
... 16 D3.4 Standardization Suggestions
... 17 Artifacts Summary
.... 17.1 INCISIVE FHIR Server CapabilityStatement
.... 17.2 Observation-category-text
.... 17.3 Observation-category-text-value-integer
.... 17.4 Observation-component-code-value-boolean
.... 17.5 Observation-component-code-value-integer
.... 17.6 Observation-component-code-value-string
.... 17.7 Observation-component-text
.... 17.8 Observation-component-text-value-string
.... 17.9 Observation-component-value-boolean
.... 17.10 Observation-component-value-intenger
.... 17.11 Observation-component-value-string
.... 17.12 SearchParameter-DiagnosticReport-age-at-diagnosis
.... 17.13 Adjuvant treatment Breast
.... 17.14 Baseline imaging Breast
.... 17.15 Baseline imaging Colorectal
.... 17.16 Baseline imaging Lung
.... 17.17 Baseline imaging Prostate
.... 17.18 Baseline imaging result Breast
.... 17.19 Baseline imaging result Colorectal
.... 17.20 Baseline imaging result Lung
.... 17.21 Boost Breast
.... 17.22 Breast cancer type
.... 17.23 ChemoImmunotherapy (CIT) Breast
.... 17.24 ChemoImmunotherapy (CIT) Colorectal
.... 17.25 ChemoImmunotherapy (CIT) Lung
.... 17.26 Chemoradiotherapy (CRT) Breast
.... 17.27 Chemoradiotherapy (CRT) Colorectal
.... 17.28 Chemoradiotherapy (CRT) Lung
.... 17.29 Chemotherapy (CTX) Breast
.... 17.30 Chemotherapy (CTX) Colorectal
.... 17.31 Chemotherapy (CTX) Lung
.... 17.32 Clinical finding Breast
.... 17.33 Clinical finding Prostate
.... 17.34 Colorectal cancer type
.... 17.35 Data Provider
.... 17.36 Delivered dose LN [Gy] Colorectal
.... 17.37 Delivered dose of RT
.... 17.38 Delivered dose of RT - Whole Breast [Gy] Breast
.... 17.39 Delivered dose of RT Lung
.... 17.40 Delivered dose Rectum [Gy] Colorectal
.... 17.41 Diagnosis report Breast
.... 17.42 Diagnosis report Colorectal
.... 17.43 Diagnosis report Lung
.... 17.44 Diagnosis report Prostate
.... 17.45 Histology - Mutations Breast
.... 17.46 Histology - Mutations Colorectal
.... 17.47 Histology - Mutations Lung
.... 17.48 Histology - Mutations Prostate
.... 17.49 Histopathology image details Breast
.... 17.50 Histopathology image details Colorectal
.... 17.51 Histopathology image details Lung
.... 17.52 Histopathology image details Prostate
.... 17.53 Hormone therapy (HT) Breast
.... 17.54 Immune therapy (IT) Breast
.... 17.55 Immune therapy (IT) Lung
.... 17.56 Lab results Breast
.... 17.57 Lab results Colorectal
.... 17.58 Lab results Lung
.... 17.59 Lab results Prostate
.... 17.60 Lung cancer type
.... 17.61 Lung nodes Lung
.... 17.62 Lymph-node surgery Breast
.... 17.63 Medical history Breast
.... 17.64 Medical history Colorectal
.... 17.65 Medical history Lung
.... 17.66 Medical history Prostate
.... 17.67 Medication
.... 17.68 Metadata
.... 17.69 Neoadjuvant treatment Breast
.... 17.70 Neoadjuvant treatment Colorectal
.... 17.71 Patient
.... 17.72 Patient demographics Breast
.... 17.73 Patient demographics Colorectal
.... 17.74 Patient demographics Lung
.... 17.75 Patient demographics Prostate
.... 17.76 Post-operative control PSA 1
.... 17.77 Post-operative control PSA 2
.... 17.78 Post-operative control PSA 3
.... 17.79 Post-operative control PSA 4
.... 17.80 Post-operative control PSA 5
.... 17.81 Post-treatment surgery Colorectal
.... 17.82 Post-treatment surgery Lung
.... 17.83 Radiation therapy (RT) Breast
.... 17.84 Radiation therapy (RT) Colorectal
.... 17.85 Radiation therapy (RT) Lung
.... 17.86 Smoker information Lung
.... 17.87 Surgery Breast
.... 17.88 Surgery Colorectal
.... 17.89 Surgery Lung
.... 17.90 Symptoms Breast
.... 17.91 Symptoms Colorectal
.... 17.92 Symptoms Lung
.... 17.93 Symptoms Prostate
.... 17.94 Targeted therapy (TT) Breast
.... 17.95 Targeted therapy (TT) Lung
.... 17.96 Timepoints imaging Breast
.... 17.97 Timepoints imaging Colorectal
.... 17.98 Timepoints imaging Lung
.... 17.99 Timepoints imaging Prostate
.... 17.100 Timepoints imaging result Lung
.... 17.101 Treatment after follow-up Breast
.... 17.102 Treatment Breast
.... 17.103 Treatment Colorectal
.... 17.104 Treatment Lung
.... 17.105 Treatment Prostate
.... 17.106 Treatment therapy Prostate
.... 17.107 Tumor profile result Breast
.... 17.108 Tumor profile result Colorectal
.... 17.109 Tumor profile result Lung
.... 17.110 Tumor profile result Prostate
.... 17.111 Condition for Breast, Colorectal, Lung and Prostate cancer
.... 17.112 DiagnosticReport for Breast, Colorectal, Lung and Prostate cancer
.... 17.113 Observation for Breast cancer
.... 17.114 Observation for Colorectal cancer
.... 17.115 Observation for Lung cancer
.... 17.116 Observation for Prostate cancer
.... 17.117 Organization for Breast, Colorectal, Lung and Prostate cancer
.... 17.118 Patient for Breast, Colorectal, Lung and Prostate cancer
.... 17.119 Procedure for Breast cancer
.... 17.120 Procedure for Lung and Colorectal cancer
.... 17.121 Procedure for Prostate cancer
.... 17.122 AgeAtDiagnosis
.... 17.123 CurrentState
.... 17.124 Ethnicity
.... 17.125 Breast_Component_Codes
.... 17.126 Cancer_Type_Codes
.... 17.127 Colorectal_Component_Codes
.... 17.128 Current_State_Codes
.... 17.129 Ethnicity_Codes
.... 17.130 IdentifierType
.... 17.131 Label_Codes
.... 17.132 Location_Codes
.... 17.133 Lung_Component_Codes
.... 17.134 Prostate_Component_Codes
.... 17.135 Prostate_Treatment_Codes
.... 17.136 Symptoms_and_Syndromes_Codes
.... 17.137 Type_of_Procedure_Codes
.... 17.138 Annotated_Dicom_files_Breast
.... 17.139 Annotated_Dicom_files_Colorectal
.... 17.140 Annotated_Dicom_files_Lung
.... 17.141 Annotated_Dicom_files_Prostate
.... 17.142 Associated_Features_Breast
.... 17.143 Baseline_location_Breast
.... 17.144 Borders_Lung
.... 17.145 Breast_BIRADS_classification
.... 17.146 Breast_Cancer_Type
.... 17.147 Breast_composition
.... 17.148 Breast_laterality
.... 17.149 Calcifications_baseline_Breast
.... 17.150 Calcifications_timepoints_Breast
.... 17.151 CM_Baseline_Prostate
.... 17.152 CN_Baseline_Prostate
.... 17.153 Colorectal_Cancer_Type
.... 17.154 CT_Baseline_Prostate
.... 17.155 Current_State_Code_System
.... 17.156 Distant_metastasis_location_baseline_Lung
.... 17.157 Distant_metastasis_location_Breast
.... 17.158 Distant_metastasis_location_Colorectal
.... 17.159 Distant_metastasis_location_timepoints_Lung
.... 17.160 Ethnicity_of_patient
.... 17.161 INCISIVE_Data_Providers
.... 17.162 Label_Biopsy
.... 17.163 Label_Exam
.... 17.164 Label_Timepoints
.... 17.165 Label_Treatment
.... 17.166 Laterality_Lung
.... 17.167 Lobe_Lung
.... 17.168 Localization_of_PIRADS_Prostate
.... 17.169 Location_Colorectal
.... 17.170 Location_for_rectal_cancer_Colorectal
.... 17.171 Location_of_RT_Colorectal
.... 17.172 Lung_Cancer_Type
.... 17.173 Lung_nodules_location
.... 17.174 Lymph_node_surgery_Breast
.... 17.175 Mass_echo_pattern_Breast
.... 17.176 Mass_Margin_Breast
.... 17.177 Mass_orientation_Breast
.... 17.178 Mass_Shape_Breast
.... 17.179 Maximum_PIRADS_Prostate
.... 17.180 Molecular_Subtype_Breast
.... 17.181 MRI_type_baseline_Prostate
.... 17.182 Parenchymal_enhancement_level_Breast
.... 17.183 Parenchymal_enhancement_symmetry_Breast
.... 17.184 PN_histology_mutations_Prostate
.... 17.185 Posterior_features_Breast
.... 17.186 Presence_of_foci_Breast
.... 17.187 Pre_post_menopause_Breast
.... 17.188 PT_histology_mutations_Prostate
.... 17.189 Response_to_treatment_Breast
.... 17.190 Response_to_treatment_Colorectal
.... 17.191 Response_to_treatment_Lung
.... 17.192 Response_to_treatment_Prostate
.... 17.193 Side_of_tumor_Prostate
.... 17.194 Smoker_Lung
.... 17.195 Solidity_Lung
.... 17.196 Symptoms_General_Info_Breast
.... 17.197 Symptoms_General_Info_Prostate
.... 17.198 Symptoms_Timepoints_Breast
.... 17.199 Syndromes_Colorectal
.... 17.200 Treatment_Prostate
.... 17.201 Type_of_Biopsy_Breast
.... 17.202 Type_of_Biopsy_Prostate
.... 17.203 Type_of_Surgery_Breast
.... 17.204 Type_of_Therapy_Prostate
.... 17.205 Adjuvant treatment model of Breast cancer to the FHIR Profile map
.... 17.206 Baseline imaging model of Breast cancer to the FHIR Profile map
.... 17.207 Baseline imaging model of Colorectal cancer to the FHIR Profile map
.... 17.208 Baseline imaging model of Lung cancer to the FHIR Profile map
.... 17.209 Baseline imaging model of Prostate cancer to the FHIR Profile map
.... 17.210 Baseline imaging result model of Breast cancer to the FHIR Profile map
.... 17.211 Baseline imaging result model of Colorectal cancer to the FHIR Profile map
.... 17.212 Baseline imaging result model of Lung cancer to the FHIR Profile map
.... 17.213 Boost model of Breast cancer to the FHIR Profile map
.... 17.214 Breast cancer type model to the FHIR Profile map
.... 17.215 ChemoImmunotherapy model of Breast cancer to the FHIR Profile map
.... 17.216 ChemoImmunotherapy model of Colorectal cancer to the FHIR Profile map
.... 17.217 ChemoImmunotherapy model of Lung cancer to the FHIR Profile map
.... 17.218 Chemoradiotherapy model of Breast cancer to the FHIR Profile map
.... 17.219 Chemoradiotherapy model of Colorectal cancer to the FHIR Profile map
.... 17.220 Chemoradiotherapy model of Lung cancer to the FHIR Profile map
.... 17.221 Chemotherapy model of Breast cancer to the FHIR Profile map
.... 17.222 Chemotherapy model of Colorectal cancer to the FHIR Profile map
.... 17.223 Chemotherapy model of Lung cancer to the FHIR Profile map
.... 17.224 Clinical finding model of Breast cancer to the FHIR Profile map
.... 17.225 Clinical finding model of Prostate cancer to the FHIR Profile map
.... 17.226 Colorectal cancer type model to the FHIR Profile map
.... 17.227 Data Provider model to the FHIR Profile map
.... 17.228 Delivered dose LN [Gy] model of Colorectal cancer to the FHIR Profile map
.... 17.229 Delivered dose of RT - Whole Breast [Gy] model of Breast cancer to the FHIR Profile map
.... 17.230 Delivered dose of RT model of Lung cancer to the FHIR Profile map
.... 17.231 Delivered dose of RT model of Prostate cancer to the FHIR Profile map
.... 17.232 Delivered dose Rectum [Gy] model of Breast cancer to the FHIR Profile map
.... 17.233 Diagnosis report model of Breast cancer to the FHIR Profile map
.... 17.234 Diagnosis report model of Colorectal cancer to the FHIR Profile map
.... 17.235 Diagnosis report model of Lung cancer to the FHIR Profile map
.... 17.236 Diagnosis report model of Prostate cancer to the FHIR Profile map
.... 17.237 Histology - Mutations model of Breast cancer to the FHIR Profile map
.... 17.238 Histology - Mutations model of Colorectal cancer to the FHIR Profile map
.... 17.239 Histology - Mutations model of Lung cancer to the FHIR Profile map
.... 17.240 Histology - Mutations model of Prostate cancer to the FHIR Profile map
.... 17.241 Histopathology image model of Breast cancer to the FHIR Profile map
.... 17.242 Histopathology image model of Colorectal cancer to the FHIR Profile map
.... 17.243 Histopathology image model of Lung cancer to the FHIR Profile map
.... 17.244 Histopathology image model of Prostate cancer to the FHIR Profile map
.... 17.245 HormoneTherapy model of Breast cancer to the FHIR Profile map
.... 17.246 HormoneTherapy model of Colorectal cancer to the FHIR Profile map
.... 17.247 ImmuneTherapy model of Breast cancer to the FHIR Profile map
.... 17.248 ImmuneTherapymodel of Lung cancer to the FHIR Profile map
.... 17.249 Lab results model of Breast cancer to the FHIR Profile map
.... 17.250 Lab results model of Colorectal cancer to the FHIR Profile map
.... 17.251 Lab results model of Lung cancer to the FHIR Profile map
.... 17.252 Lab results model of Prostate cancer to the FHIR Profile map
.... 17.253 Lung cancer type model to the FHIR Profile map
.... 17.254 Lung nodes model of Lung cancer to the FHIR Profile map
.... 17.255 Lymph-node surgery model of Breast cancer to the FHIR Profile map
.... 17.256 Medical history model of Breast cancer to the FHIR Profile map
.... 17.257 Medical history model of Colorectal cancer to the FHIR Profile map
.... 17.258 Medical history model of Lung cancer to the FHIR Profile map
.... 17.259 Medical history model of Prostate cancer to the FHIR Profile map
.... 17.260 Medication model to the FHIR Profile map
.... 17.261 Metadata model to the FHIR Profile map
.... 17.262 Neoadjuvant treatment model of Breast cancer to the FHIR Profile map
.... 17.263 Neoadjuvant treatment model of Colorectal cancer to the FHIR Profile map
.... 17.264 Patient demographics model of Breast cancer to the FHIR Profile map
.... 17.265 Patient demographics model of Colorectal cancer to the FHIR Profile map
.... 17.266 Patient demographics model of Lung cancer to the FHIR Profile map
.... 17.267 Patient demographics model of Prostate cancer to the FHIR Profile map
.... 17.268 Patient model to the FHIR Profile map
.... 17.269 Post-operative control PSA 1 model of Prostate cancer to the FHIR Profile map
.... 17.270 Post-operative control PSA 2 model of Prostate cancer to the FHIR Profile map
.... 17.271 Post-operative control PSA 3 model of Prostate cancer to the FHIR Profile map
.... 17.272 Post-operative control PSA 4 model of Prostate cancer to the FHIR Profile map
.... 17.273 Post-operative control PSA 5 model of Prostate cancer to the FHIR Profile map
.... 17.274 Post-treatment surgery model of Lung cancer to the FHIR Profile map
.... 17.275 Radiation therapy (RT) model of Breast cancer to the FHIR Profile map
.... 17.276 Radiation therapy (RT) model of Colorectal cancer to the FHIR Profile map
.... 17.277 Radiation therapy (RT) model of Lung cancer to the FHIR Profile map
.... 17.278 Smoker information model of Lung cancer to the FHIR Profile map
.... 17.279 Surgery model of Breast cancer to the FHIR Profile map
.... 17.280 Surgery model of Colorectal cancer to the FHIR Profile map
.... 17.281 Surgery model of Lung cancer to the FHIR Profile map
.... 17.282 Symptoms model of Breast cancer to the FHIR Profile map
.... 17.283 Symptoms model of Colorectal cancer to the FHIR Profile map
.... 17.284 Symptoms model of Lung cancer to the FHIR Profile map
.... 17.285 Symptoms model of Prostate cancer to the FHIR Profile map
.... 17.286 Targeted therapy (TT) model of Breast cancer to the FHIR Profile map
.... 17.287 Targeted therapy (TT) model of Lung cancer to the FHIR Profile map
.... 17.288 Timepoints imaging model of Breast cancer to the FHIR Profile map
.... 17.289 Timepoints imaging model of Colorectal cancer to the FHIR Profile map
.... 17.290 Timepoints imaging model of Lung cancer to the FHIR Profile map
.... 17.291 Timepoints imaging model of Prostate cancer to the FHIR Profile map
.... 17.292 Timepoints imaging result model of Lung cancer to the FHIR Profile map
.... 17.293 Treatment after follow-up model of Breast cancer to the FHIR Profile map
.... 17.294 Treatment model of Breast cancer to the FHIR Profile map
.... 17.295 Treatment model of Colorectal cancer to the FHIR Profile map
.... 17.296 Treatment model of Lung cancer to the FHIR Profile map
.... 17.297 Treatment model of Prostate cancer to the FHIR Profile map
.... 17.298 Treatment therapy model of Prostate cancer to the FHIR Profile map
.... 17.299 Tumor profile result model of Breast cancer to the FHIR Profile map
.... 17.300 Tumor profile result model of Colorectal cancer to the FHIR Profile map
.... 17.301 Tumor profile result model of Lung cancer to the FHIR Profile map
.... 17.302 Tumor profile result model of Prostate cancer to the FHIR Profile map
.... 17.303 Breast-Cancer-Message-Bundle-Example
.... 17.304 Colorectal-Cancer-Message-Bundle-Example
.... 17.305 Lung-Cancer-Message-Bundle-Example
.... 17.306 Prostate-Cancer-Message-Bundle-Example

INCISIVE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952179. However, the content of this website reflects the opinion of its authors and does not in any way represent opinions of the European Union. European Commission is not responsible for any use that may be made of the information the website contains.
https://ec.europa.eu/digital-single-market/en/policies/ehealth